Skip to search formSkip to main contentSkip to account menu

BeneFIX

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
ObjectivesTo develop a recombinant human factor IX (rFIX) formulation equivalent to commercially available products in terms of… 
2017
2017
2017
2017
To develop a recombinant human factor IX (rFIX) formulation equivalent to commercially available products in terms of cake… 
2016
2016
• Because extravascular FIX is physiologically important, FIXs circulating levels do not independently predict hemostatic… 
Highly Cited
2014
Highly Cited
2014
Summary Due to variability in the one-stage clotting assay, the performance of new factor IX (FIX) products should be assessed in… 
2013
2013
Head‐on comparative studies of factor IX (FIX) concentrates performed under standardized conditions are rarely conducted… 
2011
2011
Abstract 2266 Recombinant Factor IX Fc fusion (rFIXFc) was designed to be a long-lasting version of recombinant FIX that has the… 
1999
1999
The effects of a recombinant factor IX product (BeneFix), and of five plasma‐derived factor IX products, AlphaNine, Immunine…